AxoGen - 39 Year Stock Price History | AXGN
Historical daily share price chart and data for AxoGen since 1986 adjusted for splits and dividends. The latest closing stock price for AxoGen as of August 19, 2025 is 15.36.
- The all-time high AxoGen stock closing price was 55.90 on July 23, 2018.
- The AxoGen 52-week high stock price is 21.00, which is 36.7% above the current share price.
- The AxoGen 52-week low stock price is 9.22, which is 40% below the current share price.
- The average AxoGen stock price for the last 52 weeks is 14.58.
| AxoGen Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 14.9431 | 16.4000 | 20.1100 | 9.2900 | 15.3600 | -6.80% |
| 2024 | 10.2816 | 6.9100 | 17.1900 | 5.6700 | 16.4800 | 141.29% |
| 2023 | 7.7263 | 9.8800 | 10.9500 | 3.6100 | 6.8300 | -31.56% |
| 2022 | 9.5826 | 9.9800 | 13.0900 | 6.9900 | 9.9800 | 6.51% |
| 2021 | 17.4408 | 17.5100 | 23.5000 | 8.8000 | 9.3700 | -47.65% |
| 2020 | 12.0046 | 17.3400 | 17.9600 | 7.3500 | 17.9000 | 0.06% |
| 2019 | 17.7071 | 20.6300 | 25.4700 | 11.1800 | 17.8900 | -12.43% |
| 2018 | 37.4971 | 27.9500 | 55.9000 | 17.0900 | 20.4300 | -27.81% |
| 2017 | 16.0429 | 8.9000 | 28.6000 | 8.8000 | 28.3000 | 214.44% |
| 2016 | 6.8839 | 5.0500 | 9.3600 | 4.6100 | 9.0000 | 80.00% |
| 2015 | 3.9120 | 3.6000 | 5.6400 | 3.0200 | 5.0000 | 39.28% |
| 2014 | 3.0089 | 4.8100 | 4.8600 | 2.1500 | 3.5900 | -20.04% |
| 2013 | 4.0078 | 2.7500 | 5.0800 | 2.7500 | 4.4900 | 66.30% |
| 2012 | 2.9554 | 2.6000 | 3.9900 | 2.2500 | 2.7000 | 0.00% |
| 2011 | 2.7243 | 4.0000 | 4.0000 | 2.0000 | 2.7000 | -22.64% |
| 2010 | 3.5251 | 3.4923 | 5.3100 | 2.7000 | 3.4900 | 3.17% |
| 2009 | 3.4051 | 2.3142 | 4.7546 | 1.6830 | 3.3829 | 46.18% |
| 2008 | 2.4680 | 1.0940 | 4.2076 | 1.0940 | 2.3142 | 111.54% |
| 2007 | 1.9296 | 0.7153 | 6.3114 | 0.4628 | 1.0940 | 100.00% |
| 2006 | 0.3851 | 0.4292 | 0.6732 | 0.2020 | 0.5470 | 27.45% |
| 2005 | 1.1855 | 1.2340 | 2.4268 | 0.4292 | 0.4292 | -65.22% |
| 2004 | 0.9347 | 0.5758 | 1.4807 | 0.4936 | 1.2340 | 85.20% |
| 2003 | 0.3989 | 0.4031 | 0.8144 | 0.2139 | 0.6663 | 58.83% |
| 2002 | 0.8048 | 1.3409 | 2.3692 | 0.1892 | 0.4195 | -60.77% |
| 2001 | 1.5274 | 1.5424 | 2.3445 | 0.8309 | 1.0694 | -30.67% |
| 2000 | 2.1416 | 1.2340 | 4.0875 | 0.8226 | 1.5424 | 15.38% |
| 1999 | 2.2591 | 2.1080 | 3.3420 | 1.0797 | 1.3368 | -38.09% |
| 1998 | 3.1784 | 4.5245 | 4.7301 | 1.9538 | 2.1594 | -48.78% |
| 1997 | 5.2068 | 5.5528 | 7.4037 | 3.7019 | 4.2160 | -29.31% |
| 1996 | 8.3782 | 9.0490 | 12.6480 | 4.9358 | 5.9641 | -34.09% |
| 1995 | 8.6366 | 6.2726 | 11.7225 | 5.9641 | 9.0490 | 51.72% |
| 1994 | 7.1623 | 7.4429 | 8.6377 | 5.5528 | 5.9641 | -27.50% |
| 1993 | 8.2405 | 8.5807 | 9.3269 | 6.7154 | 8.2263 | -2.00% |
| 1992 | 7.5260 | 7.5993 | 9.8967 | 5.1251 | 8.3942 | 6.74% |
| 1991 | 6.1006 | 2.4742 | 10.7804 | 2.1207 | 7.8644 | 217.86% |
| 1990 | 3.0019 | 2.8276 | 3.7112 | 2.2975 | 2.4742 | -9.68% |
| 1989 | 3.5847 | 3.6229 | 4.9484 | 2.7393 | 2.7393 | -26.19% |
| 1988 | 3.6020 | 3.5346 | 4.4182 | 3.0044 | 3.7112 | 5.00% |
| 1987 | 3.4860 | 3.0044 | 4.5949 | 2.4742 | 3.5346 | 17.65% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.713B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.101B | 22.27 |
| Intuitive Surgical (ISRG) | United States | $172.528B | 71.51 |
| IDEXX Laboratories (IDXX) | United States | $51.032B | 53.11 |
| Edwards Lifesciences (EW) | United States | $45.970B | 30.47 |
| Alcon (ALC) | Switzerland | $43.470B | 29.38 |
| IQVIA Holdings (IQV) | United States | $32.732B | 18.50 |
| DexCom (DXCM) | United States | $31.694B | 47.54 |
| Mettler-Toledo (MTD) | United States | $27.012B | 32.06 |
| STERIS (STE) | Ireland | $24.087B | 25.64 |
| Waters (WAT) | United States | $17.226B | 23.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.782B | 0.00 |
| Hologic (HOLX) | United States | $14.962B | 16.21 |
| Penumbra (PEN) | United States | $9.958B | 72.75 |
| Sysmex ADR (SSMXY) | Japan | $8.391B | 26.66 |
| Masimo (MASI) | United States | $8.362B | 28.14 |
| Globus Medical (GMED) | United States | $8.137B | 18.77 |
| Teleflex (TFX) | United States | $5.297B | 8.55 |
| Glaukos (GKOS) | United States | $5.134B | 0.00 |
| TransMedics (TMDX) | United States | $4.283B | 65.10 |
| Integer Holdings (ITGR) | United States | $3.698B | 18.45 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.65 |
| Veracyte (VCYT) | United States | $2.366B | 32.69 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.265B | 0.00 |
| Artivion (AORT) | United States | $2.022B | 102.02 |
| Nihon Kohden (NHNKY) | Japan | $1.999B | 23.86 |
| Elekta AB (EKTAY) | Sweden | $1.847B | 17.28 |
| OPKO Health (OPK) | United States | $1.111B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.095B | 6.27 |
| Pulse Biosciences (PLSE) | United States | $1.055B | 0.00 |
| IRadimed (IRMD) | United States | $0.892B | 43.28 |
| Beta Bionics (BBNX) | United States | $0.750B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.732B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 9.22 |
| Semler Scientific (SMLR) | United States | $0.500B | 4.01 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.376B | 9.57 |
| Delcath Systems (DCTH) | United States | $0.373B | 88.75 |
| AngioDynamics (ANGO) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.35 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.232B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.180B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.076B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 20.89 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |